Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $61,390 | 20 | 38.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,225 | 21 | 36.7% |
| Food and Beverage | $19,947 | 292 | 12.6% |
| Travel and Lodging | $18,818 | 50 | 11.9% |
| Gift | $120.00 | 2 | 0.1% |
| Education | $83.76 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $76,830 | 114 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $26,459 | 61 | $0 (2024) |
| ABBVIE INC. | $15,674 | 49 | $0 (2024) |
| Shionogi Inc | $10,398 | 13 | $0 (2020) |
| Medtronic USA, Inc. | $7,872 | 45 | $0 (2020) |
| Saol Therapeutics Inc. | $4,640 | 12 | $0 (2021) |
| Ipsen Innovation | $4,546 | 7 | $0 (2017) |
| Merz Pharmaceuticals, LLC | $4,072 | 27 | $0 (2024) |
| Flowonix Medical Incorporated | $2,154 | 2 | $0 (2022) |
| Medtronic, Inc. | $1,925 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,846 | 37 | ABBVIE INC. ($5,126) |
| 2023 | $3,399 | 36 | Ipsen Biopharmaceuticals, Inc ($815.94) |
| 2022 | $20,743 | 58 | ABBVIE INC. ($9,802) |
| 2021 | $19,345 | 30 | Allergan, Inc. ($13,028) |
| 2020 | $18,051 | 32 | Shionogi Inc ($10,398) |
| 2019 | $28,381 | 55 | Allergan Inc. ($11,411) |
| 2018 | $23,120 | 86 | Allergan Inc. ($13,683) |
| 2017 | $36,700 | 58 | Allergan Inc. ($26,268) |
All Payment Transactions
392 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/12/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Neurology | ||||||
| 11/09/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $70.96 | General |
| Category: Drug Infusion Systems | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $66.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $56.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $145.12 | General |
| Category: Neurology | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/15/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $117.02 | General |
| Category: Pain Management | ||||||
| 10/10/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $86.76 | General |
| Category: Neurology | ||||||
| 08/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $102.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/26/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $59.79 | General |
| Category: Neurology | ||||||
| 08/20/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $97.60 | General |
| Category: Drug Infusion Systems | ||||||
| 07/17/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $60.88 | General |
| Category: Musculoskeletal | ||||||
| 06/18/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: NEUROLOGY | ||||||
| 06/01/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Neurology | ||||||
| 05/21/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $149.94 | General |
| Category: Neurology | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: NEUROLOGY | ||||||
| 05/14/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $109.76 | General |
| Category: Musculoskeletal | ||||||
| 05/10/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $116.41 | General |
| Category: Neuromodulation | ||||||
| 05/01/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: Musculoskeletal | ||||||
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: NEUROLOGY | ||||||
| 04/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/02/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $83.71 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 139 | 208 | $54,171 | $12,860 |
| 2022 | 6 | 133 | 226 | $48,145 | $11,862 |
| 2021 | 6 | 153 | 247 | $46,551 | $12,111 |
| 2020 | 5 | 161 | 259 | $52,320 | $13,978 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 34 | $15,504 | $3,196 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 28 | $8,876 | $2,187 | 24.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 31 | $6,200 | $2,013 | 32.5% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 14 | 24 | $9,720 | $1,963 | 20.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 31 | $3,193 | $1,268 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 22 | $4,906 | $1,041 | 21.2% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 11 | 14 | $3,444 | $819.11 | 23.8% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 17 | 24 | $2,328 | $373.50 | 16.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 70 | $14,000 | $3,960 | 28.3% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 16 | 33 | $13,365 | $2,690 | 20.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 39 | 64 | $6,592 | $1,915 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $6,840 | $1,789 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 14 | $4,438 | $1,043 | 23.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 14 | 30 | $2,910 | $464.59 | 16.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 47 | 85 | $17,000 | $4,777 | 28.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 49 | 84 | $8,652 | $2,605 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 23 | $7,291 | $1,763 | 24.2% |
| 64644 | Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles | Office | 2021 | 12 | 19 | $7,695 | $1,647 | 21.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 21 | $4,683 | $1,081 | 23.1% |
| 95873 | Electrical stimulation for guidance with injection of chemical for destruction of muscles | Office | 2021 | 12 | 15 | $1,230 | $237.84 | 19.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 44 | 86 | $17,200 | $5,223 | 30.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 64 | 111 | $11,433 | $3,674 | 32.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 24 | 27 | $12,312 | $2,325 | 18.9% |
| 64644 | Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles | Office | 2020 | 13 | 19 | $7,695 | $1,694 | 22.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 16 | $3,680 | $1,062 | 28.9% |
About Dr. Cindy Ivanhoe, MD
Dr. Cindy Ivanhoe, MD is a Physical Medicine & Rehabilitation healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740217397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cindy Ivanhoe, MD has received a total of $158,583 in payments from pharmaceutical and medical device companies, with $8,846 received in 2024. These payments were reported across 392 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($61,390).
As a Medicare-enrolled provider, Ivanhoe has provided services to 586 Medicare beneficiaries, totaling 940 services with total Medicare billing of $50,811. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Houston, TX
- Active Since 06/27/2006
- Last Updated 02/08/2011
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1740217397
Products in Payments
- BOTOX (Biological) $70,441
- DYSPORT (Drug) $15,717
- BOTOX NEURO REHAB (Drug) $9,544
- BOTOX (Drug) $9,300
- Dysport (Drug) $8,499
- Dysport 300 U-1 (Drug) $8,054
- Lioresal (baclofen) (Drug) $4,491
- SYNCHROMED (Device) $4,293
- Xeomin (Biological) $4,262
- LIORESAL (Device) $2,617
- Prometra II (Device) $2,154
- SYNCHROMEDII (Device) $1,165
- ADAPTIVESTIM (Device) $937.39
- XEOMIN (Biological) $492.35
- ASCENDA (Device) $422.05
- BOTOX THERAPEUTIC (Biological) $397.72
- NUEDEXTA (Drug) $347.74
- GABLOFEN 1 mL in 1 SYRINGE, GLASS (Drug) $279.49
- HA MINUTEMAN G3-R (Device) $204.17
- INTELLIS ADAPTIVESTIM (Device) $185.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Houston
Dr. Gerard Francisco, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $556,498
Dr. Suzanne Manzi, M.d., Faapmr, M.D., FAAPMR
Physical Medicine & Rehabilitation — Payments: $195,379
Gunjan Patel, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $153,260
Sheng Li, Md, Phd, MD, PHD
Physical Medicine & Rehabilitation — Payments: $38,565
Xin Wang, Md, MD
Physical Medicine & Rehabilitation — Payments: $30,788
Ankur Mehta, Do, DO
Physical Medicine & Rehabilitation — Payments: $30,036